CLDN1 and chronic kidney disease: The aim of this study was to investigate whether the expression of the key TJ proteins occludin and claudin-1 is altered in the intestinal mucosa of patients with stage I–IV CKD or ESKD, contributing to systemic endotoxemia and inflammatory responses.